Skip to main content
TTrialFinderData
TrialFinderData is for informational purposes only and does not provide medical advice. Always talk to your doctor.

Radiotherapy; Complications Clinical Trials

Reviewed by TrialFinderData Editorial Team · Updated

3 recruiting trials for Radiotherapy; Complications. Eligibility criteria explained in plain English.

TrialFinderData lists 3 Radiotherapy; Complications clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.

Research is led by Fondazione Policlinico Universitario Campus Bio-Medico (1), Clinica Universidad de Navarra, Universidad de Navarra (1), Nanjing First Hospital, Nanjing Medical University (1), among the most active sponsors registered for these trials.

The most frequently studied intervention is Radiotherapy (radiation, 1 trial), followed by Brachytherapy, Recombinant Human Thyroid Stimulating Hormone.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
3
Total Trials
3
Recruiting Now
0
Phase 3 Trials
3
Sponsors

Track Radiotherapy; Complications trials

Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.

Recruiting Trials

Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.

RECRUITINGNCT07021911

Concomitant Radiotherapy and New Drugs in Metastatic Breast Cancer

The primary objective of the study is to describe the tolerance profile of radiation treatments performed during systemic treatment with new drugs (molecular targeted therapies,...

Sponsor: Fondazione Policlinico Universitario Campus Bio-MedicoEnrolling: 3001 location
RECRUITINGNCT06982469

High Dose Rate (HDR) Brachytherapy Salvage After Prostatectomy

The goal of this observational study is to learn about the long-term effects of HDR Brachytherapy in men with isolated local relapses after radical prostatectomy. The main...

Sponsor: Clinica Universidad de Navarra, Universidad de NavarraEnrolling: 201 location
RECRUITINGNCT06405217

Recombinant Human Thyroid Stimulating Hormone for Radioiodine 131I Treatment

Subjects: patients with postoperative local recurrent or metastatic differentiated thyroid cancer . Experimental group: Recombinant human thyroid stimulating hormone injection:...

Sponsor: Nanjing First Hospital, Nanjing Medical UniversityEnrolling: 301 location

Frequently Asked Questions

There are currently 3 clinical trials for Radiotherapy; Complications, with 3 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.

To join a clinical trial for Radiotherapy; Complications, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.

Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Radiotherapy; Complications, representing treatments closest to potential FDA approval.

Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.

Sources: ClinicalTrials.gov, FDA
Last updated:

Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.